Home LiteratureArticle Details
PMID: 7856734 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.

The American journal of pathology ·Vol. 146 ·No. 1 ·1995-01-00 ·Pages 276-88

Boivin GP, O'Toole BA, Orsmby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB

Abstract

Null-mutant (knockout) mice were obtained through disruption of the sixth exon of the endogenous transforming growth factor-beta 1 allele in murine embryonic stem cells via homologous recombination. Mice lacking transforming growth factor-beta 1 (mutants) were born grossly indistinguishable from wild-type littermates. With time, mutant mice exhibited a wasting phenotype that manifested itself in severe weight loss and dishevelled appearance (between 15 and 36 days of age). Examination of these moribund mice histologically revealed that transforming growth factor-beta 1-deficient mice exhibit a moderate to severe, multifocal, organ-dependent, mixed inflammatory cell response adversely affecting the heart, stomach, diaphragm, liver, lung, salivary gland, and pancreas. Because of the known multifunctional nature of transforming growth factor-beta 1 on the control of growth and differentiation of many different cell types, it is important to determine the degree to which the inflammatory response interacts with or masks other deficiencies that are present. To this end, we examined the extent and nature of the inflammatory lesions in different ages of neonatal knockout mice (5, 7, 10, and 14 days of age) and older moribund mice (> 15 days of age) and compared them with the histology seen in wild-type normal animals. Mild inflammatory infiltrates were first observed in 5-day mutant mice in the heart, by day 7 in the lung, salivary gland, and pancreas, and by day 14 inflammatory lesions were found in almost all organs examined. Moderate to severe inflammation was not present until the mice were 10 to 14 days old. In the older animals, there was a slight increase in the severity of the inflammatory lesions as the mice aged.

MeSH Terms
Animals Base Sequence Disease Models, Animal Flow Cytometry Genotype Inflammation/genetics,immunology,pathology Mice Mice, Knockout Molecular Sequence Data Transforming Growth Factor beta/genetics Weight Gain
Chemicals
Transforming Growth Factor beta
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Boivin G P
Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, OH 45267-0529.
O'Toole B A
Orsmby I E
Diebold R J
Eis M J
Doetschman T
Kier A B
References (23)
23 references, click to expand
  1. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6076-80 PMID: 7687059
  2. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers.
    Gastroenterology. 1993 Jul;105(1):93-101 PMID: 8514065
  3. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):5187-91 PMID: 8197206
  4. Maternal rescue of transforming growth factor-beta 1 null mice.
    Science. 1994 Jun 24;264(5167):1936-8 PMID: 8009224
  5. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
    J Exp Med. 1987 Aug 1;166(2):571-6 PMID: 3110354
  6. Transforming growth factor beta: possible roles in the regulation of normal and leukemic hematopoietic cell growth.
    J Cell Biochem. 1989 Feb;39(2):175-84 PMID: 2654150
  7. The cell biology of transforming growth factor beta.
    Biochim Biophys Acta. 1990 Jun 1;1032(1):79-87 PMID: 2194569
  8. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.
    Cell. 1990 Jul 13;62(1):175-85 PMID: 2163767
  9. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.
    J Exp Med. 1990 Dec 1;172(6):1777-84 PMID: 2258706
  10. The transforming growth factor-beta family.
    Annu Rev Cell Biol. 1990;6:597-641 PMID: 2177343
  11. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918-21 PMID: 2011600
  12. The role of transforming growth factor-beta in hematopoiesis. A review.
    Leuk Res. 1991;15(4):179-84 PMID: 2030598
  13. TGF-beta: problems and prospects.
    Cell Regul. 1990 Nov;1(12):875-82 PMID: 2100192
  14. Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
    J Clin Immunol. 1992 Mar;12(2):61-74 PMID: 1313827
  15. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing.
    Surgery. 1992 Aug;112(2):299-307; discussion 307-8 PMID: 1353641
  16. Pulmonary and gastrointestinal manifestations of Sjögren's syndrome.
    Rheum Dis Clin North Am. 1992 Aug;18(3):617-35 PMID: 1496165
  17. Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.
    Exp Hematol. 1992 Sep;20(8):943-50 PMID: 1505639
  18. Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats.
    Transplantation. 1992 Sep;54(3):515-9 PMID: 1412732
  19. Transforming growth factor-beta 1 in heart development.
    Mech Dev. 1992 Aug;38(2):85-97 PMID: 1419851
  20. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
    Nature. 1992 Oct 22;359(6397):693-9 PMID: 1436033
  21. Localization of targets for anti-ulcer drugs in cells of the immune system.
    Science. 1992 Dec 4;258(5088):1662-5 PMID: 1333642
  22. Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study.
    Circulation. 1993 Apr;87(4):1340-53 PMID: 8462156
  23. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9944-8 PMID: 8234339
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1995-01-00
Pages
276-88
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1870775
Subset
IM
Grants
PHS HHS · P01 46826 · United States
NHLBI NIH HHS · P01 HL4196 · United States
NICHD NIH HHS · R01 HD 26471 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com